Transcode Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Transcode Therapeutics, Inc. has filed 323 SEC EDGAR filings since 18 Dec 2020

SEC filing history

Showing 126-150 of 323 matching filings.

Per page
25
Current page
6
424B5 File 333-268764

424B5

Filing date
24 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-268764

424B5

Filing date
22 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92695

SC 13D

Filing date
21 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jun 2024
Reporting date
14 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jun 2024
Reporting date
14 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jun 2024
Reporting date
14 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jun 2024
Reporting date
14 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-40363

FORM 8-K/A

Filing date
14 Jun 2024
Reporting date
13 Jun 2024
Next action
Verify source filing
DEFA14A File 001-40363

DEFA14A

Filing date
10 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40363

DEFA14A

Filing date
07 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 001-40363

DEFR14A

Filing date
20 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40363

DEFA14A

Filing date
13 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40363

PRE 14A filing

Filing date
10 May 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40363

ARS

Filing date
29 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40363

DEF 14A

Filing date
29 Apr 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92695

SC 13G/A

Filing date
15 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92695

AMENDMENT NO. 1

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .